SCN1A and epilepsy: For example, mutations in SCN1A have been reported to cause epilepsy with the symptoms ranging from febrile seizures and GEFS+ to SMEI, and mutations in SCN2A are identified to cause BFNIS, GEFS+, SMEI, and intractable epilepsy with mental decline [86–89].